Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tonix Pharmaceuticals Presented Data On Its Potential Mpox Vaccine TNX-801 In "Using Synthetic Biology To Battle Mpox" Talk At Immunology Symposium At The University Of Alberta, TNX-801 Vaccination Demonstrated Efficacy In Protecting Animals From Lethal Challenge With Clade I Mpox

Author: Benzinga Newsdesk | September 09, 2024 07:11am

New data show improved tolerability in immunocompromised animals and no evidence of spreading to blood or tissues even at high doses
Tonix's synthetic horsepox vaccine platform has been selected by NIH's Project NextGen for clinical testing

Posted In: TNXP